featured – Page 15

HDSA FAQ on the Roche/Genentech RG6042 program

HDSA's frequently asked questions factsheet about the huntingtin-lowering trial ASO program was so good we stole it (with permission)

October 18, 2018

Amazing news from Ionis and Roche! HTTRx drug successfully lowers harmful huntingtin protein in spinal fluid

December 11, 2017

CRISPR genome editing just got an off-switch. We cut through the hype to explore the technology in HD

November 2, 2017

Ionis says its trial of HTTRx, intended to lower huntingtin protein, is fully recruited and plans to extend it

June 22, 2017

Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease

April 5, 2017

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

December 16, 2016

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD

September 30, 2016

HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore

June 13, 2016

A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!

March 10, 2016

Stem cells and modeling Huntington's disease in our final Therapeutics Conference report

February 28, 2016